Treating Alzheimer’s patients with TPS: A revolutionary therapeutic concept

Transcranial Pulse Stimulation (TPS®) with the NEUROLITH® system is a new therapy option for patients with Alzheimer’s disease that allows targeted stimulation of cerebral regions.

Key-facts:

• TPS® are shock waves which allow highly focal brain stimulation deep in the brain.
• TPS® allows unprecedented precision for targeting brain areas.
  
• TPS® avoids brain heating and generation of secondary stimulation maxima.

• TPS® has shown to
  - modulate neuronal responses (SEP data)
  - stimulate neuroplastic reorganization (fMRI data)
  - reduce cortical atrophy (MR cortical thickness data)
  - improve brain performance in AD
  - recent clinical observations indicate motor improvements in Parkinson’s*
• TPS® has been proven to be safe in more than 2,500 human applications.

*The clinical study for the treatment of Parkinson's patients with the NEUROLITH® system directed by Prof. Dr Roland Beisteiner, started September 2020 at MedUni Vienna.

• For more information please visit our website:
   storzmedical.com: https://www.storzmedical.com/en/disciplines/neurology/neurolith